Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 600 participants.

Also called NCT05247424

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 600 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05247424
Other papers using this trial's data
  • Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN-STEMI Randomized Controlled Trial Circulation, 2026-05-19 DOI, PubMed 41910504

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Slovenia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05247424. Randomized; single masking; primary purpose treatment. Start 2022-03-10 (actual); primary completion 2025-02-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
Acronym
UFH-STEMI
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Drug)
Unfractionated heparin
Lead sponsor
University Medical Centre Ljubljana (class: other)

Record details

Record id
cardio:ct-nct05247424
Content hash
3cc0e2a5e4d047d58e808e936df470557474c26d9f4e47fc3bbb068e1a5b97c8